New clinical trials from University Hospitals Seidman Cancer Center to begin with human protein following successful on-site approach to producing and using anti-CD19 CAR T cells against B-cell malignancies
CLEVELAND- Newly designed chimeric antigen receptor (CAR) T-cells targeting the CD19 antigen are effective in treating adults and children with ...